Jafron Biomedical (China) Today
| 300529 Stock | 26.05 0.26 1.01% |
PerformanceVery Weak
| Odds Of DistressLow
|
Jafron Biomedical is trading at 26.05 as of the 23rd of March 2025, a 1.01 percent increase since the beginning of the trading day. The stock's open price was 25.79. Jafron Biomedical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Jafron Biomedical is entity of China. It is traded as Stock on SHE exchange. The company has 798.6 M outstanding shares. More on Jafron Biomedical Co
Moving together with Jafron Stock
| 0.66 | 601328 | Bank of Communications Earnings Call This Week | PairCorr |
Moving against Jafron Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Jafron Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Jafron Biomedical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Jafron Biomedical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
Jafron Biomedical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Jafron Biomedical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsJafron Biomedical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Jafron Biomedical's financial leverage. It provides some insight into what part of Jafron Biomedical's total assets is financed by creditors.
| |||||
Jafron Biomedical Co (300529) is traded on Shenzhen Stock Exchange in China and employs 2,408 people. Jafron Biomedical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 20.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jafron Biomedical's market, we take the total number of its shares issued and multiply it by Jafron Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Jafron Biomedical operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 798.6 M outstanding shares.
Jafron Biomedical generates positive cash flow from operations, but has no cash available
Check Jafron Biomedical Probability Of Bankruptcy
Ownership AllocationJafron Biomedical Co has a total of 798.6 Million outstanding shares. Jafron Biomedical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Jafron Ownership Details
Jafron Biomedical Risk Profiles
Although Jafron Biomedical's alpha and beta are two of the key measurements used to evaluate Jafron Biomedical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.2 | |||
| Standard Deviation | 1.72 | |||
| Variance | 2.97 | |||
| Risk Adjusted Performance | (0.11) |
Jafron Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Jafron Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Jafron Biomedical Corporate Directors
Other Information on Investing in Jafron Stock
Jafron Biomedical financial ratios help investors to determine whether Jafron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jafron with respect to the benefits of owning Jafron Biomedical security.